![Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib]()
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomibBerenson, Ariana; Vardanyan, Suzie; David, Michael; Wang, James; Harutyunyan, Nika Manik; Gottlieb, Jillian; Halleluyan, Ran; Spektor, Tanya M.; Udd, Kyle A.; Eshaghian, Shahrooz; Nassir, Youram; Eades, Benjamin; Swift, Regina; Berenson, James R. · Annals of Hematology · 2017